Chu de Nice - Hôpital L'archet 1

Nice 06202

2 studies enrolling now · 4 studies all time

What they study most

Chronic Myelomonocytic Leukemia (CMML), Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS), Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Acute, Metastatic Merkel Cell Carcinoma, Multiple Myeloma, Myelodysplastic Syndrome (MDS)/AML, Myelodysplastic Syndromes, Myelodysplastic Syndromes (MDS), Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Studies at this site

• Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation — Recruiting now
• A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) — Recruiting now
• A Study to Evaluate S227928 as a Single Agent and in Combination With Venetoclax in Patients With R/R AML, MDS/AML, or CMML — Stopped early
• A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201) — Completed